Carlsmed, Inc. Increase (Decrease) in Deferred Compensation
Carlsmed, Inc. (CARL) reported Increase (Decrease) in Deferred Compensation of -$1.88 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredCompensation · last filed 2026-08-05
- Carlsmed, Inc. increase (decrease) in deferred compensation for the quarter ending 2026-06-30 was $1.09M, a 15.43% increase year-over-year.
- Carlsmed, Inc. increase (decrease) in deferred compensation for the quarter ending 2026-03-31 was -$2.98M.
- Carlsmed, Inc. increase (decrease) in deferred compensation for the quarter ending 2025-12-31 was $1.35M, a 2.60% decline year-over-year.
- Carlsmed, Inc. increase (decrease) in deferred compensation for the quarter ending 2025-09-30 was $1.30M, a 274.57% increase year-over-year.
- Carlsmed, Inc. increase (decrease) in deferred compensation for fiscal 2025 was $2.49M, a 105.11% increase from fiscal 2024.
- Carlsmed, Inc. increase (decrease) in deferred compensation for fiscal 2024 was $1.21M.
| Period end | Increase (Decrease) in Deferred Compensation 3 month | Increase (Decrease) in Deferred Compensation 6 month | Increase (Decrease) in Deferred Compensation 9 month | Increase (Decrease) in Deferred Compensation 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.09M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$1.88M 10-Q · filed 2026-08-05 | -$533.00K derived: sum of 3 quarters · filed 2026-08-05 | $763.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | -$2.98M 10-Q · filed 2026-05-05 | -$1.63M derived: sum of 2 quarters · filed 2026-05-05 | -$329.00K derived: sum of 3 quarters · filed 2026-05-05 | $617.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $1.35M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $2.65M derived: sum of 2 quarters · filed 2026-02-25 | $3.59M derived: sum of 3 quarters · filed 2026-08-05 | $2.49M 10-K · filed 2026-02-25 |
| 2025-09-30 | $1.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $2.24M derived: sum of 2 quarters · filed 2026-08-05 | $1.14M 10-Q · filed 2025-11-06 | $2.53M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $946.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$157.00K 10-Q · filed 2026-08-05 | $1.23M derived: sum of 3 quarters · filed 2026-08-05 | $1.58M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | -$1.10M 10-Q · filed 2026-05-05 | $284.00K derived: sum of 2 quarters · filed 2026-05-05 | $630.00K derived: sum of 3 quarters · filed 2026-05-05 | |
| 2024-12-31 | $1.39M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $1.73M derived: sum of 2 quarters · filed 2026-02-25 | $1.21M 10-K · filed 2026-02-25 | |
| 2024-09-30 | $346.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$173.00K 10-Q · filed 2025-11-06 | ||
| 2024-06-30 | -$519.00K 10-Q · filed 2025-08-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |